Skip to content
AnalystLens

Omega Healthcare Investors Annual Report, Year Ended Dec 31, 2023

Filing Date
Filed February 12, 2024
Period End
December 31, 2023
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 10-K filed February 12, 2024. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Parent") is a Maryland corporation that invests in healthcare-related real estate in the U.S. and the U.K., with a portfolio at December 31, 2023 of 891 healthcare facilities operated by 74 third-party operators across 42 states and the U.K.

Total revenues were $949.7 milliona in 2023, up from $878.2 million in 2022, driven primarily by rental income of $825.4 million (up from $750.2 million), though the filing attributes much of the improvement to fewer straight-line rent write-offs ($8.1 million in 2023 versus $122.9 million in 2022). Net income was $248.8 million in 2023 versus $438.8 million in 2022, reflecting lower gains on asset sales ($79.7 million versus $360.0 million) and $91.9 million of real estate impairments. Nareit FFO was $591.2 million, compared with $460.5 million in 2022.

Operator stress remains the central investor concern. As of December 31, 2023, 19 operators were on a cash basis of revenue recognition, representing 23.9%b of total revenues (excluding write-offs). Several operators, including LaVie, Maplewood and Guardian, short-paid or deferred rent during 2023, and the company restructured their leases and loans, applied security deposits, and sold facilities.

Total debt was $5.1 billionc, with a weighted average interest rate of 4.4%, and the company reported cash and cash equivalents of $442.8 million. Stockholders' equity was $3.57 billion at year end.

The filing also highlights regulatory exposure, including CMS proposed minimum staffing rules for skilled nursing facilities and the expiration of the 6.2% Medicaid FMAP add-on. The 2024 dividend was declared at $0.67d per share quarterly, consistent with the $2.68 annual rate paid in 2023.

Key Highlights

  1. Total revenues rose to $949.7 million in 2023 from $878.2 million in 2022, while net income available to common stockholders fell to $242.2 million from $426.9 million.
  2. Nareit FFO increased to $591.2 million in 2023 from $460.5 million in 2022, a $130.6 million increase the filing attributes to higher revenues, lower acquisition costs and lower credit loss provisions.
  3. 19 operators, representing 23.9% of total revenues (excluding write-offs), were on a cash basis of revenue recognition at December 31, 2023.
  4. Real estate impairments of $91.9 million on 25 facilities were recorded in 2023, compared with $38.5 million on 22 facilities in 2022.
  5. The company sold 69 facilities for approximately $585.0 million in net cash proceeds in 2023, recognizing net gains of $79.7 million.
  6. Total debt was $5.1 billion at a weighted average interest rate of 4.4%, with about 99% of debt obligations having fixed interest payments after swaps; the company held $442.8 million in cash.
  7. Dividends paid in 2023 totaled $2.68 per share, and the Board declared a $0.67 per share dividend on January 26, 2024; no shares were repurchased under the $500 million program in 2023.

Financial Statements

FY2023 against FY2022

Line itemFY2023FY2022Change
Revenue$949.74M$878.24M+8.1%
Operating Expenses$793.58M$799.67M−0.8%
Interest Expense$235.53M$233.24M+1.0%
Net Income$242.18M$426.93M−43.3%
EPS (Basic)$1.01$1.81−44.2%
EPS (Diluted)$1.00$1.80−44.4%
Shares Outstanding (Basic)240.49M236.26M+1.8%
Shares Outstanding (Diluted)250.45M244.29M+2.5%

Frequently Asked Questions

  1. Why did net income decline in 2023 despite higher rental income?

    Net income was $248.8 million in 2023 versus $438.8 million in 2022. The filing shows gain on assets sold fell by $280.3 million (to $79.7 million from $360.0 million), and impairments on real estate rose to $91.9 million from $38.5 million. These offset the $75.2 million increase in rental income, which was driven largely by fewer straight-line rent write-offs.

  2. How exposed is the portfolio to operators that are struggling to pay rent?

    The filing identifies 19 operators on a cash basis of revenue recognition, which represent 23.9% of 2023 total revenues (excluding write-offs). Maplewood, LaVie and Guardian each short-paid contractual rent in 2023, with Maplewood's total short pay at $11.5 million and LaVie's at $21.1 million. The company has responded through restructurings, rent deferrals and applying security deposits.

  3. What are the main regulatory risks facing the company's operators?

    CMS issued proposed minimum staffing rules requiring nursing homes to provide 0.55 hours of registered nurse care and 2.45 hours of nurse aide care per resident per day, with CMS estimating that three quarters of nursing homes would need to add staff. The 6.2% Medicaid FMAP add-on was phased out as of December 31, 2023. A CMS final rule effective January 16, 2024 also requires SNFs to disclose ownership and relationships with REITs.

  4. How is the company funding its capital needs and debt maturities?

    At December 31, 2023 the company had $442.8 million of cash and $1.4 billion of availability under its revolving credit facility, plus $708.2 million of remaining sales under its ATM program. It sold 11.0 million shares for $339.0 million gross proceeds in 2023 and has $400 million of 4.95% senior notes due April 2024. Its credit ratings were Baa3 from Moody's and BBB- from S&P Global and Fitch.